Anti-diabetic effects of Inonotus obliquus polysaccharides-chromium (III) complex in type 2 diabetic mice and its sub-acute toxicity evaluation in normal mice

Food Chem Toxicol. 2017 Oct;108(Pt B):498-509. doi: 10.1016/j.fct.2017.01.007. Epub 2017 Jan 11.


Polysaccharides are important bioactive ingredients from Inonotus obliquus. This study aimed to synthesize and characterize a novel I. obliquus polysaccharides-chromium (III) complex (UIOPC) and investigate the anti-diabetic effects in streptozotocin (STZ) induced type 2 diabetes mellitus (T2DM) mice and sub-acute toxicity in normal mice. The molecular weight of UIOPC was about 11.5 × 10 4 Da with the chromium content was 13.01% and the chromium was linked with polysaccharides through coordination bond. After treatment of UIOPC for four weeks, the body weight, fasting blood glucose (FBG) levels, plasma insulin levels of the diabetic mice were significantly reduced when compared with those of the diabetic mice (p < 0.05). The results on serum profiles and antioxidant enzymes activities revealed that UIOPC had a positive effect on hypoglycemic and antioxidant ability. Histopathology results showed that UIOPC could effectively alleviate the STZ-lesioned tissues in diabetic mice. Furthermore, high dose administration of UIOPC had no obviously influence on serum profiles levels and antioxidant ability of the normal mice and the organ tissues maintained organized and integrity in the sub-acute toxicity study. These results suggested that UIOPC might be a good candidate for the functional food or pharmaceuticals in the treatment of T2DM.

Keywords: Anti-diabetes; Characterization; I. obliquus polysaccharides-chromium (III) complex; Sub-acute toxicity.

MeSH terms

  • Animals
  • Basidiomycota / chemistry*
  • Blood Glucose / drug effects
  • Body Weight / drug effects
  • Chromium / chemistry
  • Chromium / pharmacology*
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Heart / drug effects
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology*
  • Kidney / drug effects
  • Kidney / pathology
  • Liver / drug effects
  • Liver / pathology
  • Male
  • Malondialdehyde
  • Mice
  • Organ Size / drug effects
  • Pancreas / drug effects
  • Pancreas / pathology
  • Polysaccharides / chemistry
  • Polysaccharides / pharmacology*
  • Spleen / drug effects
  • Spleen / pathology
  • Thymus Gland / drug effects
  • Thymus Gland / pathology


  • Blood Glucose
  • Hypoglycemic Agents
  • Polysaccharides
  • Chromium
  • Malondialdehyde